SCIENTURE HOLDINGS, INC. Repayments of Convertible Debt
SCIENTURE HOLDINGS, INC. (SCNX) reported Repayments of Convertible Debt of $9.24 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2026-03-30
- SCIENTURE HOLDINGS, INC. repayments of convertible debt for the quarter ending 2025-12-31 was $5.91M.
- SCIENTURE HOLDINGS, INC. repayments of convertible debt for the quarter ending 2016-12-31 was $0.00.
- SCIENTURE HOLDINGS, INC. repayments of convertible debt for the quarter ending 2015-12-31 was $0.00.
- SCIENTURE HOLDINGS, INC. repayments of convertible debt for fiscal 2025 was $9.24M.
- SCIENTURE HOLDINGS, INC. repayments of convertible debt for fiscal 2016 was -$50.00K.
- SCIENTURE HOLDINGS, INC. repayments of convertible debt for fiscal 2015 was $0.00.
| Period end | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month |
|---|---|---|---|
| 2025-12-31 | $5.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $9.24M 10-K · filed 2026-03-30 | |
| 2025-09-30 | $3.33M 10-Q · filed 2025-11-12 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | -$50.00K 10-K · filed 2017-03-30 | |
| 2016-09-30 | -$50.00K 10-Q · filed 2016-11-14 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $0.00 10-K · filed 2017-03-30 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |